NEUVOGEN THERAPEUTICS
Live / Applied — Second extension granted (statement of use) (as of 31 Dec 2025)
What this means for you
Not registered yet, but its 24 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98516970
- Mark type
- Stylized text
- Filed
- 24 Apr 2024
- Published for opposition
- 10 Dec 2024
- Attorney of record
- Bret J. Danow
Goods and services
- Class 005 — Pharmaceuticals: Vaccines
Owner
- Neuvogen, Inc., San Diego, CA, US
- Neuvogen, Inc., San Diego, CA, US
Prosecution history
- 01 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Dec 2025 — CORRECTED NOA E-MAILED
- 31 Dec 2025 — SOU EXTENSION 2 GRANTED
- 17 Aug 2025 — SOU EXTENSION 2 FILED
- 31 Dec 2025 — DIVISIONAL PROCESSING COMPLETE
- 18 Aug 2025 — DIVISIONAL REQUEST RECEIVED
- 30 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Aug 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 18 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jul 2025 — SOU EXTENSION 1 GRANTED
- 30 Jul 2025 — SOU EXTENSION 1 FILED
- 30 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED